Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.7100
+0.0097 (1.39%)
At close: Jun 5, 2026, 4:00 PM EDT
0.6600
-0.0500 (-7.04%)
After-hours: Jun 5, 2026, 7:59 PM EDT
Alps Group Market Cap
Alps Group has a market cap or net worth of $118.14 million as of June 5, 2026. Its market cap has increased by 32.74% in one year.
Market Cap
118.14M
Enterprise Value
118.28M
1-Year Change
32.74%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since December 23, 2021, Alps Group's market cap has decreased from $143.00M to $118.14M, a decrease of -17.38%. That is a compound annual growth rate of -4.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 116.53M | -19.45% |
| Dec 31, 2025 | 144.67M | 230.19% |
| Dec 30, 2024 | 43.81M | -50.64% |
| Dec 29, 2023 | 88.76M | -41.77% |
| Dec 30, 2022 | 152.44M | 6.93% |
| Dec 30, 2021 | 142.56M | -0.30% |
| Dec 23, 2021 | 143.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 124.99M |
| Black Diamond Therapeutics | 124.92M |
| Cognition Therapeutics | 120.63M |
| enGene Therapeutics | 116.56M |
| NeOnc Technologies Holdings | 115.95M |
| Vivani Medical | 112.11M |
| Coya Therapeutics | 110.95M |
| Pyxis Oncology | 108.34M |